David Aviezer Insider Trading $PLX Protalix BioTherapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Aviezer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Aviezer. David Aviezer is President & CEO in Protalix BioTherapeutics, Inc. ($PLX).
David Aviezer in Protalix BioTherapeutics, Inc.
Trading Symbol: PLXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of David Aviezer: President & CEO
Holdings: 418,000 shares
Current Value: $330,220
Latest Transaction: Jul 18 2012
$PLX Market Capitalization: $78.10M
$PLX Previous Close: $0.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David Aviezer in Protalix BioTherapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 18 2012 | PLX | Protalix BioTherap ... | Aviezer David | President & CEO | Grant | A | 0.00 | 418,000 | 0 | 418,000 | 0 to 418 K |
May 04 2012 | PLX | Protalix BioTherap ... | Aviezer David | President & CEO | Option Exercise | M | 0.97 | 123,733 | 120,268 | 853,563 | |
May 04 2012 | PLX | Protalix BioTherap ... | Aviezer David | President & CEO | Option Exercise | M | 0.12 | 326,267 | 39,152 | 0 | |
May 04 2012 | PLX | Protalix BioTherap ... | Aviezer David | President & CEO | Sell | S | 7.13 | 450,000 | 3,208,500 | 0 | 450 K to 0 (-100.00 %) |
May 04 2012 | PLX | Protalix BioTherap ... | Aviezer David | President & CEO | Buy | M | 0.97 | 123,733 | 120,268 | 450,000 | 326.3 K to 450 K (+37.92 %) |
May 04 2012 | PLX | Protalix BioTherap ... | Aviezer David | President & CEO | Buy | M | 0.12 | 326,267 | 39,152 | 326,267 | 0 to 326.3 K |
Page: 1